Followers | 247 |
Posts | 49913 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Thursday, February 08, 2024 8:56:39 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent PEPG News
- PepGen to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/13/2024 08:05:00 PM
- PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 09:23:31 PM
- PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments • GlobeNewswire Inc. • 03/06/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 12:27:05 PM
- PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:49:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:33:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:29:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:00:10 PM
- PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1 • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/07/2024 09:55:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 12:36:05 PM
- PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock • GlobeNewswire Inc. • 02/07/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 01:00:09 PM
- Mary Beth DeLena Joins PepGen as General Counsel and Secretary • GlobeNewswire Inc. • 01/17/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:36 PM
- PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping • GlobeNewswire Inc. • 01/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 01:00:08 PM
- PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1 Clinical Trial of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1) • GlobeNewswire Inc. • 12/18/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 01:00:09 PM
- PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors • GlobeNewswire Inc. • 11/15/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 01:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 01:00:09 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM